Filya Zhebrovska, Chairman of the Supervisory Board of Farmak JSC, has joined the ranks of the rating of top managers in Ukraine carried out by Focus magazine. It’s worth noting that two women are in this rating and she is one of them.
Filya Zhebrovska started her career at Farmak JSC in 1980.
Management style: corporate.
Business principle: to build a successful company – a market leader – you need to set goals correctly and identify your key values.
Hobbies: traveling, swimming.
Favorite holiday destination: Madeira Island
Favorite book: “Lyubomyr Huzar. I Want to be a Human Being” by Kateryna Shchetkina.
The toughest management decision: to create a team of like-minded people. I succeeded in it.
My advice to a career-minded person: you need to set an ambitious goal and move towards it, it’s a thorny path and success can’t be achieved immediately.
In 2017, she decided to leave the post of the Chairman of Farmak JSC, which has 6.5% of the Ukrainian pharmaceutical market. This step is due to the fact that the company decided to separate strategic work from its business operations.
Filya Zhebrovska deals with setting global goals in her capacity as the Chair of the Supervisory Board.
Sales volumes increased by 21% in 2017. Its share of exports increased on 2016 and came to 25.2%. Export development is among the key issues on the company’s agenda.
Farmak intends to sell about 40% of its output abroad by 2020. One of the company’s strategies is to increase production volumes in Ukraine.
Interview of Filya Zhebrovska, Chairman of Farmak Supervisory Board, to The Leadership: about courses at the University of Bologna, Validol preference in Poland and a new generation of pharmacists The pharmaceutical company “Farmak” harmonically corresponds to the topic of our next issue “Titans of economy”. The participants of this topic are ent...
The article on sustainable development of “Farmak” was published in Focus. Upon joining the UN Global Compact, the world’s largest corporate social responsibility initiative, JSC “Farmak” became the first pharmaceutical company in our country that proves not by word, but by deed its commitment to main sustainable development goal — improving the living...